Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia 6Wilms Tumor 3Leukemia, Myeloid, Acute 3Congenital Abnormalities 3Sarcoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Kidney Neoplasms 2Glioblastoma 2Central Nervous System Neoplasms 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Squamous Intraepithelial Lesions 1Rectal Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroblastoma 1Melanoma 1Gliosarcoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Cognition Disorders 1Brain Neoplasms 1Astrocytoma 1Anus Neoplasms 1Adrenocortical Carcinoma 1

Interventions

Temozolomide 15Radiotherapy 12Lomustine 5Carboplatin 5Vincristine 4Carmustine 4Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Chemotherapy, Adjuvant 3lonafarnib 2imetelstat 2etoposide phosphate 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Radiation 2Psychiatric Rehabilitation 2Procarbazine 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Irinotecan 2Drug Therapy 2vorasidenib 1veliparib 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1selinexor 1sargramostim 1palbociclib 1laromustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Astrocytoma × DNA Methylation × Clear all
NCT00626990 2023-09-11

CATNON

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Active not recruiting
751 enrolled 18 charts
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡